131 related articles for article (PubMed ID: 21708481)
1. What real influence does the proto-oncogene c-myc have in OSCC behavior?
Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Barros-Angueira F; Gándara-Rey JM; García-García A
Oral Oncol; 2011 Aug; 47(8):688-92. PubMed ID: 21708481
[TBL] [Abstract][Full Text] [Related]
2. [Synergism of c-myc and p16 in oral squamous cell carcinoma].
Liu NG; Shan CM; Wu SH; Lu ZH; Kang GY
Ai Zheng; 2004 Jun; 23(6):635-9. PubMed ID: 15191661
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of MYC status in oral lichen planus in patients with progression to oral squamous cell carcinoma.
Segura S; Rozas-Muñoz E; Toll A; Martín-Ezquerra G; Masferrer E; Espinet B; Rodriguez M; Baró T; Barranco C; Pujol RM
Br J Dermatol; 2013 Jul; 169(1):106-14. PubMed ID: 23461699
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.
Hu L; Liu J; Li Z; Wang C; Nawshad A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):460-482.e4. PubMed ID: 27567435
[TBL] [Abstract][Full Text] [Related]
5. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of c-myc facilitates the assessment of prognosis of OSCC patients.
Pérez-Sayáns M; Suárez-Peñaranda JM; Padín-Iruegas E; Gayoso-Diz P; Reis-De Almeida M; Barros-Angueira F; Gándara-Vila P; Blanco-Carrión A; García-García A
Oncol Rep; 2014 Apr; 31(4):1677-82. PubMed ID: 24573767
[TBL] [Abstract][Full Text] [Related]
7. Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours.
Martín-Ezquerra G; Salgado R; Toll A; Gilaberte M; Baró T; Alameda Quitllet F; Yébenes M; Solé F; Garcia-Muret M; Espinet B; Pujol RM
Br J Dermatol; 2010 Nov; 163(5):1028-35. PubMed ID: 20662834
[TBL] [Abstract][Full Text] [Related]
8. Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M.
Chuerduangphui J; Ekalaksananan T; Chaiyarit P; Patarapadungkit N; Chotiyano A; Kongyingyoes B; Promthet S; Pientong C
PLoS One; 2018; 13(1):e0192009. PubMed ID: 29385191
[TBL] [Abstract][Full Text] [Related]
9. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs: new actors in the oral cancer scene.
Wu BH; Xiong XP; Jia J; Zhang WF
Oral Oncol; 2011 May; 47(5):314-9. PubMed ID: 21474366
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of a serine-threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma.
Chiang WF; Yen CY; Lin CN; Liaw GA; Chiu CT; Hsia YJ; Liu SY
Int J Oral Maxillofac Surg; 2006 Aug; 35(8):740-5. PubMed ID: 16546353
[TBL] [Abstract][Full Text] [Related]
13. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC).
Freier K; Schwaenen C; Sticht C; Flechtenmacher C; Mühling J; Hofele C; Radlwimmer B; Lichter P; Joos S
Oral Oncol; 2007 Jan; 43(1):60-6. PubMed ID: 16807070
[TBL] [Abstract][Full Text] [Related]
14. microRNA expression profiles in oral squamous cell carcinoma.
Soga D; Yoshiba S; Shiogama S; Miyazaki H; Kondo S; Shintani S
Oncol Rep; 2013 Aug; 30(2):579-83. PubMed ID: 23708842
[TBL] [Abstract][Full Text] [Related]
15. Oncogene amplification in squamous cell carcinoma of the oral cavity.
Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Sumegi J; Klein G; Deo MG
Jpn J Cancer Res; 1989 May; 80(5):430-7. PubMed ID: 2502519
[TBL] [Abstract][Full Text] [Related]
16. Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis.
Koehn J; Krapfenbauer K; Huber S; Stein E; Sutter W; Watzinger F; Erovic BM; Thurnher D; Schindler T; Fountoulakis M; Turhani D
J Proteome Res; 2008 Sep; 7(9):3818-29. PubMed ID: 18700792
[TBL] [Abstract][Full Text] [Related]
17. Significance of c-Myc and Bcl-2 protein expression in nasopharyngeal carcinoma.
Yu Y; Dong W; Li X; Yu E; Zhou X; Li S
Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1322-6. PubMed ID: 14676159
[TBL] [Abstract][Full Text] [Related]
18. Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress.
Talwar S; Jin J; Carroll B; Liu A; Gillespie MB; Palanisamy V
J Biol Chem; 2011 Sep; 286(37):32333-43. PubMed ID: 21795698
[TBL] [Abstract][Full Text] [Related]
19. Review article: The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation.
Sugerman PB; Joseph BK; Savage NW
Oral Dis; 1995 Sep; 1(3):172-88. PubMed ID: 8705824
[TBL] [Abstract][Full Text] [Related]
20. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
